Metraipolis › archive › dc_b5ceaf06b1ea
Empirical Meropenem Versus Piperacillin/Tazobactam for Critically Ill Adults With Sepsis: Feasibility of a Randomised Trial — Europe PMC PMID:42674465
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42674465
- DOI
- 10.1111/aas.70324
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T17:03:50.652Z
- SHA-256 of the archived text
18b912afdf76c7bb1f1e168abb78f0358770387d6681dfb5fbd319c39d6fbbc5- Stable URL of this page
https://metraipolis.com/documento/dc_b5ceaf06b1ea
How to cite
Empirical Meropenem Versus Piperacillin/Tazobactam for Critically Ill Adults With Sepsis: Feasibility of a Randomised Trial — Europe PMC PMID:42674465 — Europe PMC (en), https://europepmc.org/article/MED/42674465 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b5ceaf06b1ea (Metraipolis archive dc_b5ceaf06b1ea, sha256 18b912afdf76c7bb1f1e168abb78f0358770387d6681dfb5fbd319c39d6fbbc5)
BibTeX
@misc{dcb5ceaf06b1ea,
title = {Empirical Meropenem Versus Piperacillin/Tazobactam for Critically Ill Adults With Sepsis: Feasibility of a Randomised Trial — Europe PMC PMID:42674465},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42674465},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b5ceaf06b1ea; sha256 18b912afdf76c7bb1f1e168abb78f0358770387d6681dfb5fbd319c39d6fbbc5},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42674465. Agents can read the archived copy with the MCP tool read_document.